Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases

Theodoros V Giannouchos, Roberto A Sussman, José Manuel Mier Odriozola, Konstantinos Poulas, View ORCID ProfileKonstantinos Farsalinos
doi: https://doi.org/10.1101/2020.06.04.20122481
Theodoros V Giannouchos
1Pharmacotherapy Outcomes Research Center, University of Utah, College of Pharmacy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto A Sussman
2Instituto de Ciencias Nucleares, Universidad Nacional Autónoma de México, AP 70–543, Ciudad de México, CP 04510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Manuel Mier Odriozola
3Clinica de Cáncer de Pulmón y Tumores del Tórax, Hospital Angeles Lomas, Hacienda de las Palmas. México
4Instituto de Cirugía Torácica Mínimamente Invasiva, Hospital Angeles Lomas, Hacienda de las Palmas. México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos Poulas
5Laboratory of Molecular Biology and Immunology, Department of Pharmacy, University of Patras, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos Farsalinos
5Laboratory of Molecular Biology and Immunology, Department of Pharmacy, University of Patras, Greece
6Department of Public and Community Health, University of West Attica, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Konstantinos Farsalinos
  • For correspondence: kfarsalinos@gmail.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Data Availability

The dataset is publicly available and accessible to anyone through the Mexican Health Ministry.

Back to top
PreviousNext
Posted June 07, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases
Theodoros V Giannouchos, Roberto A Sussman, José Manuel Mier Odriozola, Konstantinos Poulas, Konstantinos Farsalinos
medRxiv 2020.06.04.20122481; doi: https://doi.org/10.1101/2020.06.04.20122481
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory–confirmed COVID-19 cases
Theodoros V Giannouchos, Roberto A Sussman, José Manuel Mier Odriozola, Konstantinos Poulas, Konstantinos Farsalinos
medRxiv 2020.06.04.20122481; doi: https://doi.org/10.1101/2020.06.04.20122481

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1103)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (504)
  • Epidemiology (9787)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2323)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1566)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11658)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2149)
  • Nursing (134)
  • Nutrition (339)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1184)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2192)
  • Public and Global Health (4676)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (211)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)